HealthCare Global Enterprises Limited Financial Results and Strategic Divestment Announcement

HealthCare Global Enterprises Limited has announced its audited financial results for the quarter and year ended March 31, 2026. Alongside its financial performance, the company disclosed the strategic divestment of its entire equity shareholding in BACC Health Care Private Limited for INR 37.64 crore. Additionally, the company confirmed key leadership appointments and updates on its rights issue and business expansion plans.

Financial Highlights for FY 2026

For the financial year ended March 31, 2026, HealthCare Global Enterprises reported consolidated revenue of INR 2,538.43 crore, compared to INR 2,218.14 crore in the previous year. The consolidated net profit for the year stood at INR 22.78 crore, demonstrating operational resilience despite various strategic adjustments.

Strategic Divestment

The company is divesting its entire stake in BACC Health Care Private Limited, a subsidiary focused on fertility and reproductive healthcare, to Inviga Healthcare Fund I. The total consideration for this transaction is INR 37.64 crore. This decision aligns with the company’s objective to focus on its core business activities, as fertility services are considered non-core.

Rights Issue and Capital Structure

During the fourth quarter of FY 2026, the company successfully completed a rights issue, allotting 8,294,566 fully paid-up equity shares at an issue price of INR 512 per share. This exercise resulted in an increase in the paid-up equity share capital by INR 8.29 crore and significantly bolstered the securities premium reserve by INR 416.39 crore.

Leadership Updates

The company has strengthened its management team with the appointment of Mr. Sanjeev Kumar as the Chief Financial Officer and Key Managerial Personnel, effective May 25, 2026. Furthermore, Mr. Ravi Gothwal has been appointed as AVP – Investor Relations, designated as a Senior Management Personnel, effective May 19, 2026. Additionally, the board approved the re-appointment of Mr. Rajiv Maliwal as a Non-Executive Independent Director for a second five-year term.

Source: BSE

Previous Article

Max Healthcare Institute Legal Petition Filed Following Kalinga Hospital Acquisition

Next Article

HealthCare Global Enterprises Limited Q4 & FY26 Financial Results and Strategic Divestment